Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
The Real World Study of Zanubrutinib in the Treatment of Chronic Lymphocytic Leukemia in China
ClinicalTrials.gov study NCT06489184. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00058396. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00290004. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-label Extension Study of Navitoclax in Subjects With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01557777. IPD Sharing: Not stated. Countries: 5. Publications: 0.
A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) .
ClinicalTrials.gov study NCT05959694. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00151736. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Effect of Digital Health Coaching Program on Self-efficacy and Patient Reported Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT04774744. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Indoleamine 2,3-dioxygenase (IDO) Activity in Patients With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01397916. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical Practice
ClinicalTrials.gov study NCT03310190. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Acalabrutinib in Combination With Venetoclax or Obinutuzumab for the Treatment of Treatment-naive Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT05336812. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice
ClinicalTrials.gov study NCT04178317. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndr
ClinicalTrials.gov study NCT00038805. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Effectiveness and Patient Acceptance of the Treatment With MabCampath in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00836043. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01016990. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece
ClinicalTrials.gov study NCT04159779. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO
ClinicalTrials.gov study NCT04502030. IPD Sharing: NO. Countries: 12. Publications: 0.
A Study to Evaluate Impact of Ibrutinib on the Quality of Life (QOL) in Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT04016636. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
AZD2171 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00321724. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chronic Lymphocytic Leukemia Registry Study - Multicenter Prospective National Study
ClinicalTrials.gov study NCT03197259. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Frontline Treatment With Bendamustine in Combination With Rituximab in Adults Age 65 or Older With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00758693. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.